HBK Sorce Advisory LLC Grows Position in BlackRock Health Sciences Trust $BME

HBK Sorce Advisory LLC boosted its stake in BlackRock Health Sciences Trust (NYSE:BME) by 27.1% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,602 shares of the company’s stock after purchasing an additional 2,476 shares during the quarter. HBK Sorce Advisory LLC’s holdings in BlackRock Health Sciences Trust were worth $423,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Comerica Bank grew its stake in BlackRock Health Sciences Trust by 7.9% during the first quarter. Comerica Bank now owns 4,807 shares of the company’s stock worth $186,000 after buying an additional 353 shares during the period. Oppenheimer & Co. Inc. increased its position in shares of BlackRock Health Sciences Trust by 8.4% in the first quarter. Oppenheimer & Co. Inc. now owns 6,295 shares of the company’s stock worth $243,000 after acquiring an additional 486 shares in the last quarter. Stratos Wealth Partners LTD. increased its position in shares of BlackRock Health Sciences Trust by 7.9% in the first quarter. Stratos Wealth Partners LTD. now owns 7,037 shares of the company’s stock worth $272,000 after acquiring an additional 517 shares in the last quarter. Cetera Investment Advisers increased its position in shares of BlackRock Health Sciences Trust by 4.6% in the first quarter. Cetera Investment Advisers now owns 12,414 shares of the company’s stock worth $480,000 after acquiring an additional 546 shares in the last quarter. Finally, Royal Bank of Canada increased its position in shares of BlackRock Health Sciences Trust by 0.5% in the first quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock worth $5,546,000 after acquiring an additional 684 shares in the last quarter.

BlackRock Health Sciences Trust Price Performance

BlackRock Health Sciences Trust stock opened at $38.33 on Friday. BlackRock Health Sciences Trust has a 52-week low of $34.18 and a 52-week high of $41.36. The firm has a fifty day moving average of $37.26 and a 200-day moving average of $36.54.

BlackRock Health Sciences Trust Announces Dividend

The firm also recently disclosed a monthly dividend, which was paid on Friday, October 31st. Stockholders of record on Wednesday, October 15th were given a $0.2621 dividend. The ex-dividend date of this dividend was Wednesday, October 15th. This represents a c) annualized dividend and a dividend yield of 8.2%.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.